GOLDMAN SACHS GROUP INC - ROCK CREEK PHARMACEUTICALS I ownership

ROCK CREEK PHARMACEUTICALS I's ticker is RCPIQ and the CUSIP is 772081204. A total of 38 filers reported holding ROCK CREEK PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ROCK CREEK PHARMACEUTICALS I
ValueSharesWeighting
Q2 2015$16,00010,8260.00%
Other shareholders
ROCK CREEK PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
Talkot Capital, LLC 75,291$62,0000.05%
TENOR CAPITAL MANAGEMENT Co., L.P. 115,011$94,0000.02%
Crosspoint Capital Strategies, LLC 7,580$6,0000.01%
Tower Research Capital LLC (TRC) 18,116$15,0000.00%
Virtu KCG Holdings LLC 31,116$26,0000.00%
Advisory Services Network, LLC 2$00.00%
BRAVE ASSET MANAGEMENT INC 600$00.00%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 20$00.00%
UBS Group AG 2,362$2,0000.00%
BLACKROCK ADVISORS LLC 3,008$2,0000.00%
View complete list of ROCK CREEK PHARMACEUTICALS I shareholders